HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bonser, R. S. Articles by Vergani, D. Search for Related Content PubMed PubMed Citation Articles by Bonser, R. S. Articles by Vergani, D.

European Journal of Cardio-Thoracic Surgery, Vol 4, 291-296, Copyright © 1990 by European Association for Cardio-thoracic Surgery

ARTICLES

Complement activation before, during and after cardiopulmonary bypass

RS Bonser, JR Dave, L John, MK Gademsetty, PG Carter, E Davies, P Taylor, H Gaya, SC Lennox and D Vergani
Department of Surgery, Brompton Hospital, London, UK.

Plasma levels of the complement parent molecules C3, C4, and factor B and their split products, C3d, C4d, and Ba were measured in 12 patients undergoing cardiopulmonary bypass for coronary artery surgery. Alternative and common complement pathway activation, demonstrated by statistically significant rising levels of Ba (P less than 0.05), and C3d (P less than 0.05) and by elevated Ba:B (P less than 0.05) and C3d:C3 (P less than 0.05) ratios were found before the institution of cardiopulmonary bypass but following heparin administration suggesting that heparin may itself initiate alternative pathway activation. In addition, significant depletion of parent complement components and elevation of split product concentrations was seen during bypass suggesting classical and alternate pathway activation (P less than 0.01). This study clarifies the pathways of complement activation during bypass and presents evidence that heparin administration may initially activate the complement cascade.

This article has been cited by other articles:

				A. Fabbri, J. Manfredi, C. Piccin, G. Soffiati, M. R. Carta, E. Gasparotto, and G. Nardon Systemic leukocyte filtration during cardiopulmonary bypass Perfusion, January 1, 2001; 16(1_suppl): 11 - 18. [Abstract] [PDF]

				V. Videm, T. E. Mollnes, K. Bergh, E. Fosse, B. Mohr, T.-A. Hagve, A. O. Aasen, and J. L. Svennevig HEPARIN-COATED CARDIOPULMONARY BYPASS EQUIPMENT. II. MECHANISMS FOR REDUCED COMPLEMENT ACTIVATION IN VIVO J. Thorac. Cardiovasc. Surg., April 1, 1999; 117(4): 803 - 809. [Abstract] [Full Text] [PDF]

				G. Zund, R. Pretre, U. Niederhauser, P. R. Vogt, and M. I. Turina Improved exposure of the pulmonary arteries for thromboendarterectomy Ann. Thorac. Surg., November 1, 1998; 66(5): 1821 - 1823. [Abstract] [Full Text] [PDF]

				S. Bannan, A. Danby, D. Cowan, S. Ashraf, and P. G. Martin Low Heparinization With Heparin-Bonded Bypass Circuits: Is It a Safe Strategy? Ann. Thorac. Surg., March 1, 1997; 63(3): 663 - 668. [Abstract] [Full Text]

				E. D. Verrier and E. M. Boyle Jr Endothelial Cell Injury in Cardiovascular Surgery Ann. Thorac. Surg., September 1, 1996; 62(3): 915 - 922. [Abstract] [Full Text]

				P. Menasche, J. Peynet, N. Haeffner-Cavaillon, M.-P. Carreno, T. de Chaumaray, V. Dillisse, B. Faris, A. Piwnica, G. Bloch, and A. Tedgui Influence of Temperature on Neutrophil Trafficking During Clinical Cardiopulmonary Bypass Circulation, November 1, 1995; 92(9): 334 - 340. [Abstract] [Full Text]

				T. Mihaljevic, M. Tonz, L. K. von Segesser, M. Pasic, P. Grob, J. Fehr, B. Seifert, and M. Turina The influence of leukocyte filtration during cardiopulmonary bypass on postoperative lung function: A clinical study J. Thorac. Cardiovasc. Surg., June 1, 1995; 109(6): 1138 - 1145. [Abstract] [Full Text]